首页> 外文期刊>World Journal of Surgery: Official Journal of the Societe Internationale de Chirurgie, Collegium Internationale Chirurgiae Digestivae, and of the International Association of Endocrine Surgeons >Preoperative 18F-FDG uptake is strongly correlated with malignancy, weiss score, and molecular markers of aggressiveness in adrenal cortical tumors
【24h】

Preoperative 18F-FDG uptake is strongly correlated with malignancy, weiss score, and molecular markers of aggressiveness in adrenal cortical tumors

机译:术前摄取18F-FDG与肾上腺皮质肿瘤的恶性程度,魏斯评分和侵袭性分子标志密切相关

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Adrenal incidentaloma are frequent in the general population. It can be difficult to diagnose adrenocortical carcinomas among them, even with the progress of imaging techniques. We studied the results of PET-FDG in the diagnosis of such tumours. Methods We studied patients referred to the Department of Endocrine Surgery at La Timone Hospital, Marseilles, France, between June 2006 and October 2010 for adrenal tumours. All patients underwent a complete work-up (biological tests and imagery), completed with PET-FDG. We compared the results of PET-FDG and molecular analysis with Weiss score and clinical follow-up. We calculated correlations with the Pearson test. Results A total of 51 patients were studied. We found that PET-FDG had a sensitivity of 95% and specificity of 97% for the diagnosis of adrenocortical carcinoma. The correlation between PET-FDG and Weiss score was 77% (P < 0.0001). Molecular analyses were correlated as well with Weiss score and malignancy (P < 0.05). Conclusions The nature of atypical adrenal masses can be difficult to define during preoperative investigations. For undetermined tumours smaller than 6 cm, characterization with PET-FDG can be one more diagnostic argument pointing to malignancy. It could potentially change the therapeutic strategy and surgical management. In our experience, molecular analyses are available after surgery and have less impact on the therapeutic strategy than PETFDG. Preoperative PET-FDG can be an asset in the management of adrenal incidentaloma and adrenocortical carcinoma.
机译:背景肾上腺偶发瘤在普通人群中很常见。即使随着成像技术的进步,也可能难以诊断其中的肾上腺皮质癌。我们研究了PET-FDG在此类肿瘤诊断中的结果。方法我们研究了2006年6月至2010年10月间转诊至法国马赛La Timone医院内分泌外科的患者的肾上腺肿瘤。所有患者均接受了PET-FDG的完整检查(生物学检查和图像检查)。我们将PET-FDG和分子分析的结果与Weiss评分和临床随访进行了比较。我们用皮尔逊检验计算了相关性。结果共对51例患者进行了研究。我们发现,PET-FDG诊断肾上腺皮质癌的敏感性为95%,特异性为97%。 PET-FDG与Weiss评分之间的相关性为77%(P <0.0001)。分子分析也与Weiss评分和恶性肿瘤相关(P <0.05)。结论非典型肾上腺肿块的性质可能难以在术前检查中确定。对于小于6 cm的未定肿瘤,PET-FDG表征可能是恶性的另一诊断依据。它可能会改变治疗策略和手术管理。根据我们的经验,分子分析可在手术后进行,并且与PETFDG相比对治疗策略的影响较小。术前PET-FDG可能是治疗肾上腺偶发瘤和肾上腺皮质癌的一项资产。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号